Evaluation of the prognostic value of HER-2 and VEGF in breast cancer patients participating in a randomized study with dose–dense sequential adjuvant chemotherapy
Ioannis Kostopoulos, Petroula Arapantoni-Dadioti, Helen Gogas, Savvas Papadopoulos, Vasiliki Malamou-Mitsi, Chrisoula D. Scopa, Sofia Markaki, Evangelia Karagianni, Vasiliki Kyriakou, Anastasia MargarVolume:
96
Language:
english
Pages:
11
DOI:
10.1007/s10549-005-9062-2
Date:
April, 2006
File:
PDF, 406 KB
english, 2006